We are live on
!
Find out more
CC
Capital Counsel Portfolio holdings
AUM
$2.35B
1-Year Est. Return
21.34%
This Fund
S&P 500
This Quarter
Est. Return
-6.32%
1 Year Est. Return
+21.34%
3 Year Est. Return
+69.88%
5 Year Est. Return
+102.01%
10 Year Est. Return
+473.12%
AUM
$1.21B
AUM Growth
-$228M
(-16%)
Cap. Flow
-$103M
Cap. Flow
% of AUM
-8.53%
Top 10 Holdings %
Top 10 Hldgs %
81.74%
Holding
60
New
1
Increased
3
Reduced
22
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$12.3M |
| 2 |
Costco
COST
|
+$978K |
| 3 |
SiriusXM
SIRI
|
+$122K |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$94K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
S&P Global
SPGI
|
+$26.5M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$23.1M |
| 3 |
Ecolab
ECL
|
+$18.7M |
| 4 |
AL
Air Lease Corp
AL
|
+$6.85M |
| 5 |
Core Laboratories
CLB
|
+$5.52M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 28.31% |
| 2 | Financials | 23.03% |
| 3 | Communication Services | 14.37% |
| 4 | Technology | 11.94% |
| 5 | Industrials | 7.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
JPMorgan Chase
JPM
$935B
| $244K | 0.02% |
2,501
-3
| -0.1% | -$320 |
|
52
Norfolk Southern
NSC
$75.4B
| $238K | 0.02% |
1,590
| – | – |
|
53
Thermo Fisher Scientific
TMO
$213B
| $232K | 0.02% |
1,035
| – | – |
|
|
54
Core Laboratories
CLB
$488M
| – | – |
-47,627
| Closed | -$5.52M |
|
55
Walt Disney
DIS
$167B
| – | – |
-1,725
| Closed | -$202K |
|
|
56
S&P Global
SPGI
$121B
| – | – |
-135,753
| Closed | -$26.5M |
|
|
POLY
57
DELISTED
Plantronics, Inc.
POLY
| – | – |
-6,000
| Closed | -$362K |
|
|
ESRX
58
DELISTED
Express Scripts Holding Company
ESRX
| – | – |
-242,640
| Closed | -$23.1M |
|
Similar funds
HFM
ROIC
EC
SCA
G
MC
BAM
BJL
Capital Counsel's Q4 2018 Portfolio in Review
As of Q4 2018, Capital Counsel held 60 positions worth $1.21B, down 16% from $1.43B the previous quarter. Its ten largest holdings account for 82% of the portfolio.
Capital Counsel withdrew a net $103M in Q4 2018, closing 6 positions and reducing 22 holdings. Its most notable exit was S&P Global, an estimated $26.5M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 29% a quarter earlier, followed by Financials and Communication Services.
Against the trend, Capital Counsel opened a new position in Cigna worth $11.2M.
- Capital Counsel's largest Q4 2018 buy was Cigna: 59,056 shares worth $11.2M.
- Capital Counsel added most to Costco in Q4 2018, an estimated $978K increase.
- Capital Counsel's biggest Q4 2018 reduction was Ecolab, cutting an estimated $18.7M.
- Capital Counsel fully exited S&P Global in Q4 2018, selling an estimated $26.5M.
- Capital Counsel's ten largest holdings make up 82% of its $1.21B portfolio in Q4 2018.
- Capital Counsel opened 1 new position and closed 6 in Q4 2018.
- Capital Counsel's portfolio value fell 16% quarter-over-quarter to $1.21B.
Based on Capital Counsel's 13F filing for Q4 2018, filed 13 Feb 2019.